the vla spp, page-5

'Given the above scenario, I would hope to see a reasonably quick recovery in the share price back up to the 40-41 cent level at least, despite the dilutionary effect of the new shares.'

Agree with your sentiments on VLA, but the quoted comment is slightly flawed.

The dilution shouldn't in theory affect the share price much at all, because in exchange for more shares the company has more cash.

Admittedly the shares were issued at a discount, but with the fall in market cap caused by the SPP this has already been over compensated for.

So if we simply had a return to the pre SPP market cap, remembering that cash forms part of that market cap, there should be a solid appreciation of share price. We both agree on that!

By the way, apropos of what Big Doc was saying about them being damned if they do, damned if they don't re timing of capital raisings, my feeling is that this company is mainly focused on running a professional outfit in terms of the medical and scientific side of the business and not concentrating as much on the share price side of things. This is both good and bad, depending on your investment time frame.

Personally I'd prefer them to get the curing cancer side of the business right and stuff the share price in the short term than get the medical side wrong due to lack of funds and stuff the share price in the long term. However, I can see how a short or medium term trader would be a bit frustrated. The solution is to extend your time frame... don't look at the share price for 6 months and you should get a nice surprise.